FDA label
What is naratriptan used for?
The FDA-approved uses of naratriptan, quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “Naratriptan tablets are indicated for the acute treatment of migraine with or without aura in adults.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted naratriptan?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Naratriptan, tablet
Indications and Usage, quoted from the label by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. (ANDA200502). Cross-references to other label sections are left out.
Naratriptan tablets are indicated for the acute treatment of migraine with or without aura in adults.
Limitations of Use:
- Use only if a clear diagnosis of migraine has been established. If a patient has no response to the first migraine attack treated with naratriptan tablets reconsider the diagnosis of migraine before naratriptan tablets are administered to treat any subsequent attacks.
- Naratriptan tablets are not indicated for the prevention of migraine attacks.
- Safety and effectiveness of naratriptan tablets have not been established for cluster headache.
Source: DailyMed label, set id 41c29652-32f8-48dc-9038-0e2195aa2084, version 20, effective October 30, 2025. NDC 23155-054, one of 6 listings for this product.
Questions
What is naratriptan used for?
The FDA label says: “Naratriptan tablets are indicated for the acute treatment of migraine with or without aura in adults.”
What drug class is naratriptan?
FDA lists naratriptan in the Serotonin-1b and Serotonin-1d Receptor Agonist established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.